DBV Technologies S.A. Company Profile (NASDAQ:DBVT)

About DBV Technologies S.A. (NASDAQ:DBVT)

DBV Technologies S.A. logoDBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic & Testing Substances Manufacturers
  • Sub-Industry: N/A
  • Symbol: NASDAQ:DBVT
  • CUSIP: N/A
  • Web: www.dbv-technologies.com
Capitalization:
  • Market Cap: $2.13329 billion
  • Outstanding Shares: 46,000,000
Average Prices:
  • 50 Day Moving Avg: $36.08
  • 200 Day Moving Avg: $35.06
  • 52 Week Range: $31.87 - $44.95
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -11.16
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $8.6 million
  • Price / Sales: 236.42
  • Book Value: $5.63 per share
  • Price / Book: 7.85
Profitability:
  • EBIDTA: ($130,950,000.00)
Debt:
  • Debt-to-Equity Ratio: 0.02%
  • Current Ratio: 9.39%
  • Quick Ratio: 9.39%
Misc:
  • Average Volume: 114,752 shs.
  • Beta: 1.44
  • Short Ratio: 4.73
 

Frequently Asked Questions for DBV Technologies S.A. (NASDAQ:DBVT)

What is DBV Technologies S.A.'s stock symbol?

DBV Technologies S.A. trades on the NASDAQ under the ticker symbol "DBVT."

How were DBV Technologies S.A.'s earnings last quarter?

DBV Technologies S.A. (NASDAQ:DBVT) posted its quarterly earnings results on Thursday, March, 26th. The company reported ($0.79) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.44) by $0.35. View DBV Technologies S.A.'s Earnings History.

Where is DBV Technologies S.A.'s stock going? Where will DBV Technologies S.A.'s stock price be in 2017?

8 brokers have issued 12 month target prices for DBV Technologies S.A.'s shares. Their forecasts range from $46.00 to $54.00. On average, they anticipate DBV Technologies S.A.'s stock price to reach $48.80 in the next twelve months. View Analyst Ratings for DBV Technologies S.A..

Who are some of DBV Technologies S.A.'s key competitors?

Who are DBV Technologies S.A.'s key executives?

DBV Technologies S.A.'s management team includes the folowing people:

  • Pierre-Henri Benhamou, Chairman of the Board, Chief Executive Officer
  • David Schilansky, Chief Operating Officer
  • Hugh A. Sampson M.D., Chief Scientific Officer
  • Lucie Mondoulet, Director of Research
  • Nathalie Donne, Director of Corporate Communication & Business Development
  • Veronique Foutel, Director of Strategic Marketing
  • Wence Agbotounou, Chief Clinical Trial Officer
  • Bertrand Dupont, Industrial Director
  • Pascale Ehouarn, Industrial Development and Production Director
  • Laurent Martin, Director of Regulatory Affairs

Who owns DBV Technologies S.A. stock?

DBV Technologies S.A.'s stock is owned by many different of institutional and retail investors. Top institutional shareholders include Exane Asset Management (0.31%), GW&K Investment Management LLC (0.22%) and Sit Investment Associates Inc. (0.04%). View Institutional Ownership Trends for DBV Technologies S.A..

Who sold DBV Technologies S.A. stock? Who is selling DBV Technologies S.A. stock?

DBV Technologies S.A.'s stock was sold by a variety of institutional investors in the last quarter, including GW&K Investment Management LLC. View Insider Buying and Selling for DBV Technologies S.A..

Who bought DBV Technologies S.A. stock? Who is buying DBV Technologies S.A. stock?

DBV Technologies S.A.'s stock was acquired by a variety of institutional investors in the last quarter, including Sit Investment Associates Inc. and Exane Asset Management. View Insider Buying and Selling for DBV Technologies S.A..

How do I buy DBV Technologies S.A. stock?

Shares of DBV Technologies S.A. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DBV Technologies S.A.'s stock price today?

One share of DBV Technologies S.A. stock can currently be purchased for approximately $44.20.


MarketBeat Community Rating for DBV Technologies S.A. (NASDAQ DBVT)
Community Ranking:  3.0 out of 5 (  )
Outperform Votes:  109 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  183
MarketBeat's community ratings are surveys of what our community members think about DBV Technologies S.A. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for DBV Technologies S.A. (NASDAQ:DBVT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 8 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $48.80 (10.41% upside)

Analysts' Ratings History for DBV Technologies S.A. (NASDAQ:DBVT)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/10/2017Morgan StanleyReiterated RatingOverweightLowView Rating Details
7/6/2017HC WainwrightReiterated RatingBuy$50.00MediumView Rating Details
6/23/2017Deutsche Bank AGInitiated CoverageBuy$46.00LowView Rating Details
6/1/2017Jefferies Group LLCReiterated RatingBuy$47.00HighView Rating Details
3/15/2017Leerink SwannReiterated RatingOutperformMediumView Rating Details
3/16/2017Societe GeneraleUpgradeHold -> BuyMediumView Rating Details
2/17/2017NatixisUpgradeNeutral -> BuyN/AView Rating Details
9/26/2016JMP SecuritiesInitiated CoverageOutperform$47.00N/AView Rating Details
3/16/2016Citigroup Inc.Lower Price TargetBuy$48.00 -> $43.00N/AView Rating Details
12/3/2015Barclays PLCInitiated CoveragePositive -> Overweight$58.00N/AView Rating Details
10/23/2015Bank of America CorporationInitiated CoverageBuy$48.00N/AView Rating Details
(Data available from 7/21/2015 forward)

Earnings

Earnings History for DBV Technologies S.A. (NASDAQ:DBVT)
Earnings by Quarter for DBV Technologies S.A. (NASDAQ:DBVT)
Earnings History by Quarter for DBV Technologies S.A. (NASDAQ DBVT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/26/2015($0.44)($0.79)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for DBV Technologies S.A. (NASDAQ:DBVT)
2017 EPS Consensus Estimate: ($4.00)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.91)($0.91)($0.91)
Q2 20171($1.00)($1.00)($1.00)
Q3 20171($1.04)($1.04)($1.04)
Q4 20171($1.05)($1.05)($1.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for DBV Technologies S.A. (NASDAQ:DBVT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for DBV Technologies S.A. (NASDAQ:DBVT)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for DBV Technologies S.A. (NASDAQ:DBVT)
Latest Headlines for DBV Technologies S.A. (NASDAQ:DBVT)
Source:
DateHeadline
americanbankingnews.com logoDBV Technologies S.A. (NASDAQ:DBVT) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - July 11 at 12:20 AM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Earns "Overweight" Rating from Morgan Stanley
www.americanbankingnews.com - July 10 at 9:40 PM
finance.yahoo.com logoDBV Technologies (DBVT) Worth a Look: Stock Up 5.7%
finance.yahoo.com - July 10 at 5:47 PM
americanbankingnews.com logoDBV Technologies' (DBVT) "Buy" Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - July 6 at 4:04 PM
finance.yahoo.com logoHalf-Year Report on the DBV Technologies Liquidity Contract with Natixis
finance.yahoo.com - July 5 at 6:29 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Cut to "Sell" at ValuEngine
www.americanbankingnews.com - July 1 at 10:04 AM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Rating Increased to Hold at ValuEngine
www.americanbankingnews.com - June 24 at 10:22 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Coverage Initiated at Deutsche Bank AG
www.americanbankingnews.com - June 23 at 12:12 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Upgraded at BidaskClub
www.americanbankingnews.com - June 21 at 8:18 PM
americanbankingnews.com logoHead-To-Head Comparison: DBV Technologies (DBVT) and Meridian Bioscience (VIVO)
www.americanbankingnews.com - June 20 at 10:31 AM
americanbankingnews.com logo Analysts Expect DBV Technologies S.A. (DBVT) to Post -$0.91 Earnings Per Share
www.americanbankingnews.com - June 19 at 8:16 AM
americanbankingnews.com logoQuidel Corporation (QDEL) versus DBV Technologies (DBVT) Financial Comparison
www.americanbankingnews.com - June 18 at 7:24 AM
finance.yahoo.com logoDBV Technologies Highlights Poster Presentations on EPIT® at the 2017 EAACI Congress
finance.yahoo.com - June 17 at 3:36 AM
finance.yahoo.com logoDBV Technologies Announces Appointment of Julie O`Neill to Board of Directors
finance.yahoo.com - June 16 at 6:30 AM
americanbankingnews.com logoBidaskClub Downgrades DBV Technologies S.A. (DBVT) to Strong Sell
www.americanbankingnews.com - June 14 at 9:06 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 14 at 12:46 AM
finance.yahoo.com logoDBV Technologies : Ordinary and Extraordinary General Meeting of June 15, 2017 Procedures for Obtaining Preparatory Documents for the General Meeting
finance.yahoo.com - May 24 at 11:19 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Expected to Earn Q2 2017 Earnings of ($1.00) Per Share
www.americanbankingnews.com - May 22 at 7:12 AM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 20 at 12:12 AM
finance.yahoo.com logoDBV Technologies Highlights Research Presentation of EPIT® for the Treatment of Crohn's Disease at Digestive Disease Week 2017
finance.yahoo.com - May 8 at 9:29 AM
americanbankingnews.com logo Brokerages Expect DBV Technologies SA - (DBVT) to Announce -$0.91 Earnings Per Share
www.americanbankingnews.com - May 1 at 10:07 AM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Earning Positive Media Coverage, Analysis Finds
www.americanbankingnews.com - April 29 at 9:02 AM
finance.yahoo.com logoDBV Technologies Reports March 31, 2017 Cash Position
finance.yahoo.com - April 28 at 3:14 AM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - April 25 at 12:53 AM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - April 24 at 7:14 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Short Interest Update
www.americanbankingnews.com - April 24 at 5:53 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Given Daily Media Impact Score of 0.31
www.americanbankingnews.com - April 23 at 6:35 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Receiving Favorable Media Coverage, Report Shows
www.americanbankingnews.com - April 20 at 4:56 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Earns Daily Coverage Optimism Score of 0.56
www.americanbankingnews.com - April 17 at 12:28 PM
americanbankingnews.com logoZacks: Brokerages Expect DBV Technologies SA - (DBVT) Will Post Earnings of -$0.91 Per Share
www.americanbankingnews.com - April 8 at 12:22 AM
finance.yahoo.com logoDBV Technologies to Attend the 10th Kempen Life Sciences Conference
finance.yahoo.com - April 7 at 9:23 AM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - April 6 at 5:49 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 6 at 7:20 AM
americanbankingnews.com logoZacks Investment Research Upgrades DBV Technologies SA - (DBVT) to "Hold"
www.americanbankingnews.com - March 31 at 5:40 PM
finance.yahoo.com logoDBV Technologies, BioNet-Asia and Geneva University Hospitals Announce Phase I Trial Results of Viaskin rPT in Pertussis Booster Vaccination
finance.yahoo.com - March 30 at 5:06 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 30 at 1:43 PM
finance.yahoo.com logoDBV TECHNOLOGIES S.A. Financials
finance.yahoo.com - March 28 at 4:24 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 20 at 7:18 PM
americanbankingnews.com logoJefferies Group Equities Analysts Decrease Earnings Estimates for DBV Technologies SA - (DBVT)
www.americanbankingnews.com - March 20 at 11:38 AM
americanbankingnews.com logoFY2017 Earnings Forecast for DBV Technologies SA - Issued By Leerink Swann (DBVT)
www.americanbankingnews.com - March 20 at 11:38 AM
us.rd.yahoo.com logoDBV Technologies upgraded by Societe Generale
us.rd.yahoo.com - March 16 at 6:04 PM
finance.yahoo.com logoDBV Technologies Reports Full Year 2016 Financial Results
finance.yahoo.com - March 15 at 9:58 AM
finance.yahoo.com logoDBV Technologies Announces Completion of Enrollment of the REALISE Study in Peanut Allergic Children
finance.yahoo.com - March 10 at 3:21 AM
us.rd.yahoo.com logoA patch could fix your peanut-allergy problem
us.rd.yahoo.com - March 7 at 9:39 PM
finance.yahoo.com logoDBV Technologies :Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut Allergic Children
finance.yahoo.com - March 5 at 4:34 PM
finance.yahoo.com logoDBV Technologies Reports December 31, 2016 Cash Position
finance.yahoo.com - February 20 at 11:34 AM
finance.yahoo.com logoDBV to Present Data at the 2017 AAAAI Meeting Highlighting the Therapeutic Potential of EPIT®
finance.yahoo.com - February 18 at 8:25 AM
us.rd.yahoo.com logo3:10 am DBV Technologies completes enrollment of Phase IIA study of Viaskin Milk; expects results in 1H18
us.rd.yahoo.com - February 3 at 10:03 PM
finance.yahoo.com logoDBV Technologies Announces Financial Calendar 2017
finance.yahoo.com - January 9 at 2:37 AM
finance.yahoo.com logoDBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
finance.yahoo.com - January 4 at 5:44 PM

Social

Chart

DBV Technologies S.A. (DBVT) Chart for Friday, July, 21, 2017

This page was last updated on 7/21/2017 by MarketBeat.com Staff